跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REBIF 44 microgramos/0,5 ml SOLUCION INYECTABLE EN CARTUCHO - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
REBIF 44 microgramos/0,5 ml SOLUCION INYECTABLE EN CARTUCHO
Approved
STANDARD
REBIF 44 microgramos/0,5 ml SOLUCION INYECTABLE EN CARTUCHO
Merck Europe B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 1, 2020
Approval ID
044fe3e3566c648b
Company
Merck Europe B.V.
Type
Standard
Approval Details
Approval Id
044fe3e3566c648b
Drug Cima Aemps Name
REBIF 44 microgramos/0,5 ml SOLUCION INYECTABLE EN CARTUCHO
Register Number
98063009IP
Holder Company Name
Merck Europe B.V.
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/merck-europe-bv
Authorization Date
2020-10-01
Dosage Form
SOLUCIÓN INYECTABLE EN CARTUCHO
Dose
44 µg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Merck Europe B.V.
Company Detail Path
/organization/merck-europe-bv
Company Information
Pharmaceutical Company Name
Merck Europe BV
Country Name
Netherlands
Active Ingredients
INTERFERON BETA-1A
44 µg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 1, 2020
Approval ID
044fe3e3566c648b
Type
Standard
Back to CIMA-AEMPS Approvals